{"retracted":false,"update":{"timestamp":1398470400000,"doi":"10.1007/s00520-014-2247-7","type":"correction"},"doi":"10.1007/s00520-014-2159-6","journal":"Supportive Care in Cancer","publisher":"Springer Nature","title":"Erratum to: Osteonecrosis of the jaw (ONJ) in renal cell cancer patients after treatment including zoledronic acid or denosumab"}
